Syed Meraj Azhar Rizvi

In Vitro Cytotoxicity of Bismuth-213 (213bi)-Labeled-Plasminogen Activator Inhibitor Type 2 (Alpha-PAI-2) on Human Breast Cancer Cells

Marie Ranson, Nicholas M. Andronicos, Syed Meraj Azhar Rizvi et al. · Breast Cancer Research and Treatment · 2002 · 39 citations

Medicine, Cancer Biology, Oncology +4

Preclinical targeted alpha therapy for subcutaneous melanoma

BJ Allen, Syed Meraj Azhar Rizvi · Melanoma Research · 2001 · 35 citations

Medicine, Medicinal Chemistry, Oncology +15

The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy

Emma Song, Syed Meraj Azhar Rizvi, Chang Qu et al. · Physics in Medicine and Biology · 2007 · 31 citations

Medicine, Cell Biology, Oncology +15

Microtubule‐associated proteins, <scp>B</scp>ik1 and <scp>B</scp>im1, are required for faithful partitioning of the endogenous 2 micron plasmids in budding yeast

Hemant Kumar Prajapati, Syed Meraj Azhar Rizvi, Ishan Rathore et al. · Molecular Microbiology · 2016 · 26 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Invasive lobular carcinoma of the breast: Should this be regarded as a chronic disease?

Ihab Anwar, Sue Down, Syed Meraj Azhar Rizvi et al. · International Journal of Surgery · 2010 · 22 citations

Medicine, Oncology, Surgery +12